skip to primary navigationskip to content

The Nanoscience Centre

Cambridge University nanofabrication and characterisation facility

Studying at Cambridge

Dr Myriam Marie Ouberaï

Dr Myriam Marie Ouberaï

Senior Research Associate

Bio-Nano Interfaces


Protein sciences

Biomolecular engineering

Office Phone: 60303


2015 Senior Research Associate

Nanoscience Centre, Engineering department, University of Cambridge

Collaboration with MedImmune-AstraZeneca in peptide formulation


2014 Facilitator - Nano in Biology and Medicine - Cambridge NanoForum Strategic Network

Strategic Network of University of Cambridge

Expand interactions and build links in medical nanoscience


2010-2014 Research Associate

Nanoscience Centre, Engineering department, University of Cambridge

Develop interdisciplinary projects at the interface between nanotechnology, physics, chemistry and biology aiming to decipher the molecular processes involved in Parkinson’s disease or to improve the efficacy and safety of drugs to treat challenging diseases such as cancer and tuberculosis.


2009 Postdoctoral Fellow

Université catholique de Louvain, Cellular and Molecular Pharmacology Unit, Brussels, Belgium

Evaluation of the antimicrobial activity of drug candidates


2008 PhD in Chemistry, Biomolecular Engineering

Department of Molecular Chemistry, Joseph Fourier University, Grenoble, France

Engineering and characterization of self-assembled peptide structures

Synthesis and evaluation of peptide conjugates to prevent peptide aggregation in Alzheimer's disease

Research Interests


  • Nanomedicine - drug delivery
  • Cancer therapy
  • Peptide self-assembly
  • Parkinson’s and Alzheimer’s diseases
  • Biomolecular engineering
  • Protein interaction with lipid membranes
  • Proteins at solid-liquid interfaces


Peptide self-assembly - Nanostructures - Collaboration with MedImmune-AstraZeneca

Interdisciplinary research - Drug delivery technology

Tiny pieces of gold 'boost brain cancer therapy' in lab